Iqvia Holdings, Inc. · NYSE:IQV

Iqvia — Quintiles — Q4 2013 Earnings Presentation

14 slides from Iqvia's earnings presentation, Feb 13, 2014

  1. Slide 1: Fourth Quarter 2013 Earnings Call

    Fourth Quarter 2013 Earnings Call February 13, 2014 Copyright © 2013 Quintiles

  2. Slide 2: Forward Looking Statements and Use of Non-GAAP Financial Measures

    Forward Looking Statements and Use of Non-GAAP Financial Measures This presentation contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. Such forward-looking statements refl

  3. Slide 3: Fourth Quarter 2013 and Full Year Overview

    Fourth Quarter 2013 and Full Year Overview Solid financial results for the fourth quarter and full year 2013 • $1 billion of service revenues in the quarter; First billion dollar service revenue quarter in Quintiles’ history • 10.7% constant currency revenue growth in Product Development in the qua

  4. Slide 4: Financial Highlights and Other Metrics

    Financial Highlights and Other Metrics Three Months Ended December 31 Year Ended December 31 (millions of dollars) 2013 2012 Change 2013 2012 Change Net New Business $ 1,299.0 $ 1,507.0 -14.0% $ 4,899.0 $ 4,501.0 9.0% Service Revenues $ 1,003.9 $ 945.8 6.2% $ 3,808.3 $ 3,692.3 3.1% Adjusted Income f

  5. Slide 5: Segment Performance

    Segment Performance Service Revenues and Income from Operations Product Development Integrated Healthcare Services $775.0 $703.0 $228.9 $242.8 800 Three Months Ended 250 Three Months Ended December 31 200 $ Millions 600 $ Millions December 31 150 400 $152.9 $125.5 100 $11.7 $13.6 200 50 0 0 2013 201

  6. Slide 6: 2014 Guidance

    2014 Guidance Service Revenues range of $4.09 billion to $4.15 billion • 7.4% to 9.0% year over year projected constant currency growth Diluted Adjusted Earnings per share range of $2.33 to $2.46 • 11.0% to 17.1% year over year growth range at forecasted rates Annual Effective Income Tax Rate of app

  7. Slide 7: Summary

    Summary  Combined market of ~$200 billion 1• Product Development and Integrated Healthcare Services Market  Continue to see strength in all clinical phases (Phase I – IV) RFP volume Dynamics  Estimate growth in both markets to be 6%-8% over next few years 2• Goals accomplished in 2013 and will 

  8. Slide 8: Supplemental Information

    Supplemental Information Constant Currency Reconciliation Contractual Revenue Currency Mix and Foreign Exchange Analysis Income Statement Non-GAAP Reconciliation Adjusted Net Income and EPS Reconciliation Adjusted EBITDA Reconciliation Non-GAAP 2014 Guidance Reconciliation 8

  9. Slide 9: Constant Currency Reconciliation Service Revenues and Income from Operations

    Constant Currency Reconciliation Service Revenues and Income from Operations (millions of dollars) Three Months Ended December 31, 2013 Year on Year Growth Exchange Exchange Consolidated Actual Impact Constant Actual Impact Constant Service Revenues $ 1,003.9 $ (14.4) $ 1,018.3 6.2% -1.5% 7.7% Incom

  10. Slide 10: Contractual Revenue Currency Mix and Foreign Exchange Analysis

    Contractual Revenue Currency Mix and Foreign Exchange Analysis Consolidated Service Revenues (millions of dollars) 1 USD Sterling Euro Yen Other Total 4Q '13 $587.4 $71.1 $207.2 $108.3 $29.9 $1,003.9 % of total 59% 7% 21% 11% 2% 100% 4Q '12 $546.0 $114.1 $151.9 $109.3 $24.5 $945.8 % of total 58% 12%

  11. Slide 11: GAAP – Non-GAAP Reconciliation

    Income Statement GAAP – Non-GAAP Reconciliation 2013 2012 Selling, Income Net Income Selling, Income Net Income Three Months Ended December 31 General and from Attributable General and from Attributable (millions of dollars) Administrative Operations to Quintiles Administrative Operations to Quintil

  12. Slide 12: Reconciliation of Net Income to Non-GAAP Adjusted EBITDA

    Reconciliation of Net Income Attributable to Quintiles to Non-GAAP Adjusted EBITDA Three Months Ended December 31 Year Ended December 31 (millions of dollars) 2013 2012 2013 2012 Net Income Attributable to Quintiles $ 73.0 $ 35.0 $ 226.6 $ 177.5 Income from Noncontrolling Interests (0.1) (0.1) (0.6)

  13. Slide 13: Reconciliation to Non-GAAP Adjusted Net Income and Diluted Adjusted EPS

    Reconciliation of Net Income Attributable to Quintiles to Non-GAAP Adjusted Net Income and Diluted Adjusted EPS Three Months Ended December 31 Year Ended December 31 (millions of dollars) 2013 1 2012 1 2013 1 2012 1 EPS 1 EPS 1 EPS1 EPS1 Net Income Attributable to Quintiles $ 73.0 $ 0.55 1 $ 35.0 $

  14. Slide 14: Non-GAAP 2014 Guidance Reconciliation

    Non-GAAP 2014 Guidance Reconciliation Non-GAAP Adjusted Diluted Adjusted Net Income Earnings Per Share (millions of dollars) Low High Low High Net income attributable to Quintiles $302 - $321 $2.26 - $2.40 Restructuring costs 14 - 12 0.10 - 0.09 1 Tax effect of adjustments (4) - (4) (0.03) - (0.03)

Quintiles — Q4 2013 Earnings Presentation on 6ix